Resistance Patterns Associated with HCV NS5A Inhibitors Provide Limited Insight into Drug Binding

Direct-acting antivirals (DAAs) have significantly improved the treatment of infection with the hepatitis C virus. A promising class of novel antiviral agents targets the HCV NS5A protein. The high potency and broad genotypic coverage are favorable properties. NS5A inhibitors are currently assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Issur, Moheshwarnath, Götte, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246218/
https://www.ncbi.nlm.nih.gov/pubmed/25384189
http://dx.doi.org/10.3390/v6114227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246218/
https://www.ncbi.nlm.nih.gov/pubmed/25384189
http://dx.doi.org/10.3390/v6114227

Ejemplares similares